PS.

NHS London Branded Medicines - Tranche B - September 2023

NHS EnglandcontractFind a Tender ↗Ref ocds-h6vhtk-03b23b32014L0024active

Estimated value

—

goods

Awarded value

—

Suppliers

46

11 SME

Lots

2

46 awarded

Published

08 Aug 2023

Description

Project Title: NHS London Branded Medicines - Tranche B - September 2023<br/><br/>Offer reference number: CM/PHR/22/5677<br/><br/>CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/><br/>CM/PHR/22/5677/02 - NHS Framework for London Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

Scope

Reference
CM/PHR/22/5677
Commercial tool
Standalone contract
Contract dates
31 Aug 2023 to 31 Aug 2025
Main category
goods
CPV classifications
33600000
Contract locations
UK

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
——price—

Submission & procedure

Procedure
Open procedure

Award details· 46 awards

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

—

Award date

—

Contract start

—

Contract end

—

Awarded to
BI
Biogen
CH
Celltrion Healthcare United Kingdom Limited
SL
Sandoz Ltd
SME
ZP
Zentiva Pharma UK Ltd
TU
Takeda UK Ltd
OU
Orifarm UK
TU
Teva UK Limited
CP
CST Pharma Limited
SME
RP
Roche Products Ltd
KP
Kent Pharma Ltd
SME
PL
Pfizer Ltd
MY
Mylan
SME
JL
Janssen-Cilag Ltd
SME
EL
Eli Lilly and Company Ltd
IP
Ipsen
AL
Almirall
AP
Aventis Pharma ltd t/a Sanofi
MS
Merck Serono Limited
NP
Novartis Pharmaceuticals UK Ltd
NN
Novo Nordisk
TL
Typharm Ltd
SME
GS
Gilead Sciences Limited
NH
Neon Healthcare Ltd
SME
BP
Bayer Plc
TA
Thornton and Ross Ltd
GU
GlaxoSmithKline UK Limited
AL
Accord-UK Ltd
CH
Celltrion Healthcare United Kingdom Limited
TU
Takeda UK Ltd
OU
Orifarm UK
MS
Merck Sharpe and Dohme (UK) Limited
TU
Teva UK Limited
RP
Roche Products Ltd
AS
AstraZeneca
PL
Pfizer Ltd
AL
Abbvie Ltd
JL
Janssen-Cilag Ltd
SME
EL
Eli Lilly and Company Ltd
OP
Organon Pharmaceuticals UK Ltd
SP
Sun Pharma UK Ltd
AP
Aventis Pharma ltd t/a Sanofi
GR
Gedeon Richter UK Ltd
SME
NP
Novartis Pharmaceuticals UK Ltd
GB
Galapagos Biotech UK Ltd
SME
SO
Sobi (Swedish Orphan Biovitrum Ltd)
SME
UP
UCB Pharma Ltd

Lots · 2 total

Divisions of the contract. Each lot can be awarded separately.

View all →
LotTitleEst. valueStatus
1CM/PHR/22/5677/01 - NHS London Branded Medicines - Tranche B Lot 1£253.5mcancelled
2CM/PHR/22/5677/02 - NHS London Branded Medicines - Tranche B Lot 2£192.3mcancelled